Versatility! Top 10 benefits of virtual advisory boards
December 7, 2023 | Advisory board, Clinical trial insights, DOL advisory, HCP advisory, KOL Advisory, MSL advisory, Virtual, insight gathering, patient engagement, pharma collaboration, pharma insights
Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards.
#10. Versatility!
Another major advantage of using a virtual platform for all of your stakeholder engagement and collaboration needs is versatility. In addition to advisory boards with HCPs, patients, and payers, comprehensive online platforms such as the Impetus InSite Platform® can be used for countless other applications. These include (but are far from limited to) working groups and steering committees; medical education, training, and speaker programs; “digital offices” and HCP community boards; grant submission and review programs; patient journey mapping and treatment pathway profiling; journal clubs; virtual product launches, and much, much more!
To learn more about this and other great benefits of virtual advisory boards, check out our blog https://www.impetusdigital.com/2021/09/17/top-10-benefits-of-virtual-advisory-boards/
Interested in learning how we can help you engage your advisors, HCPs, patients, and stakeholders with expertly executed virtual meetings and programs? Visit us at www.impetusdigital.com or talk to one of our amazing team members via https://meetwithimpetus.com/
Follow us on social media
https://linkedin.com/company/impetus-digital
https://twitter.com/impetus_digital
https://facebook.com/ImpetusDigital.fb
https://impetusdigital.com/podcast/
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Navigating the rapidly changing oncology treatment landscape: how digital tools can help
With rapid growth comes growing pains...
Enhancing Focus in Virtual Meetings: Stick to a Theme - Impetus InSite Tips #5
Focus your virtual meetings with a clear theme! Tip 5 from our ImpetusInSite Tips series shows how sticking to one theme per touchpoint can dramatically improve engagement and coherence. Learn...
Effective Communication in Virtual Meetings: Stay Pithy - Impetus InSite Tips #4
Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today's fast-paced...
Enhancing Honesty in Feedback: Blinded Questions
Explore our third tip in our series aimed at refining asynchronous virtual meetings. Discover how using blinded questions can significantly minimize bias and enhance the integrity of feedback in virtual...
Streamlining Asynchronous Feedback: Scale Consistency - Impetus InSite Tips #2
Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable...
Clinical Trial Protocol Conceptualization: A Customer Story
To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical...
Mastering Asynchronous Meetings: Open-Ended Questions - Impetus Digital Tip 1
Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".
In-person, hybrid, or digital? State of Pharma meetings and events in 2024
We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.
Navigating Regulatory Challenges - Top 10 Most Important Advisor Questions
This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...
Top-5 Trends in Virtual KOL Engagement
Register now for one of our upcoming webinars (February 26-28)